The Magle Group announced that it will commence its post market clinical study in collaboration with the University of Heidelberg, Medical Faculty a world leading center in pancreatic surgery. SmartPAN® is a patented first-in-class medical device developed jointly with the University of Heidelberg and Magle Chemoswed AB. SmartPAN® is based on the patented bio-compatible and bio-degradable microsphere technology (DSM) owned by Magle Chemoswed.
Postoperative pancreatic fistula (POPF) is a common and potentially life-threatening complication after pancreatic surgery. POPF can develop due to leaking pancreatic fluid. SmartPAN® acts as an intraoperative indicator of leakage by providing a near-immediate and accurate colour indication when in contact with the pancreatic fluid. SmartPAN® provides a less complicated approach to identifying and localising pancreatic leaks that benefits patient outcomes.